Prostate cancer affects one in every eight men during their lifetime, making it the most prevalent form of cancer for males. For many, the standard of care means facing aggressive treatments that include radiation and the ...
Apr 21, 2022
0
89
A McMaster researcher is part of a team that has developed a more efficient way to screen for vitamin D deficiency that could become a tool in the fight against COVID-19 and other respiratory illnesses.
Apr 15, 2022
0
50
Researchers at the Spanish National Cancer Research Centre (CNIO), led by Dr. Manuel Valiente, have uncovered how cancer cells that have spread to the brain (metastasis) are able to resist the effects of radiotherapy. The ...
Apr 11, 2022
0
65
Pretty sure you have COVID, but unsure about what you need to do next?
Apr 4, 2022
0
12
Prostate cancers remain localized in the majority of cases, giving affected individuals a good chance of survival. However, about 20% of patients develop incurable metastatic prostate cancer, resulting in approximately 5,000 ...
Apr 4, 2022
0
9
Delirium is a serious change in brain function that affects up to 64% of older medical patients and up to 50% of older surgical patients. It can manifest as sudden confusion, agitation, memory loss or hallucinations and delusions. ...
Mar 31, 2022
0
17
Pharmacogenetic testing was associated with nearly a two-fold (89%) increase in remission rates compared to treatment as usual in a Centre for Addiction and Mental Health- (CAMH-)led clinical study just published in the journal ...
Mar 29, 2022
0
49
In the summer of 2020, Texas Tech University's Office of Research Commercialization filed a patent application and applied for the COVID-19 Prioritized Examination Pilot Program with the U.S. Patent and Trade Office.
Mar 28, 2022
0
6
In 2018, the U.S. Food and Drug Administration approved the first prescription medication derived from cannabis sativa: Epidiolex. Used to treat seizures, Epidiolex is purified formulation of cannabidiol (CBD) and has been ...
Mar 25, 2022
0
100
Mayo Clinic researchers have validated a new antibody test to diagnose multiple sclerosis (MS), a potentially disabling disease of the brain and spinal cord. Nearly 1 million people in the U.S. are affected by MS, according ...
Mar 24, 2022
0
17
